Oncodesign Services

About:

Oncodesign Services specializes in drug discovery and preclinical services.

Website: https://www.oncodesign-services.com

Twitter/X: oncodesignODS

Top Investors: Eurazeo, Edmond de Rothschild Private Equity

Description:

Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. From target identification to IND filing, the company contributes to the development of innovative therapies in oncology, inflammation and infectious diseases, with high medical needs. Through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, in vivo/In vitro pharmacology, Oncodesign Services support the R&D programs of customers with a global footprint. Based in Dijon, France, in the heart of the university and hospital cluster and within the Paris-Saclay cluster, Oncodesign Services has 230 employees in France, Canada and the United States.

Total Funding Amount:

22M EUR

Headquarters Location:

Dijon, Bourgogne, France

Founded Date:

1995-01-01

Contact Email:

contact(AT)oncodesign-services.com

Founders:

Number of Employees:

251-500

Last Funding Date:

2024-01-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai